These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 22773603
21. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations. Sugimoto Y, Muramatsu H, Makishima H, Prince C, Jankowska AM, Yoshida N, Xu Y, Nishio N, Hama A, Yagasaki H, Takahashi Y, Kato K, Manabe A, Kojima S, Maciejewski JP. Br J Haematol; 2010 Jul; 150(1):83-7. PubMed ID: 20408841 [Abstract] [Full Text] [Related]
22. SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Meggendorfer M, Roller A, Haferlach T, Eder C, Dicker F, Grossmann V, Kohlmann A, Alpermann T, Yoshida K, Ogawa S, Koeffler HP, Kern W, Haferlach C, Schnittger S. Blood; 2012 Oct 11; 120(15):3080-8. PubMed ID: 22919025 [Abstract] [Full Text] [Related]
23. Srsf2P95H/+ co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia-like disease in mice. Xu JJ, Chalk AM, Wall M, Langdon WY, Smeets MF, Walkley CR. Leukemia; 2022 Dec 11; 36(12):2883-2893. PubMed ID: 36271153 [Abstract] [Full Text] [Related]
24. Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia. Patnaik MM, Tefferi A. Blood Cancer J; 2016 Feb 05; 6(2):e393. PubMed ID: 26849014 [Abstract] [Full Text] [Related]
25. Mutational landscape of chronic myelomonocytic leukemia in Chinese patients. Nie Y, Shao L, Zhang H, He CK, Li H, Zou J, Chen L, Ji H, Tan H, Lin Y, Ru K. Exp Hematol Oncol; 2022 May 24; 11(1):32. PubMed ID: 35610628 [Abstract] [Full Text] [Related]
26. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia. Reinig E, Yang F, Traer E, Arora R, Brown S, Rattray R, Braziel R, Fan G, Press R, Dunlap J. Am J Clin Pathol; 2016 Apr 24; 145(4):497-506. PubMed ID: 27124934 [Abstract] [Full Text] [Related]
33. Morphologic and Immunophenotypic Differences in Juvenile Myelomonocytic Leukemias With CBL and Other Canonical RAS-pathway Gene Mutations: A Single Institutional Experience. Mariani RA, Jennings L, Zhang S, Bhat R, Gong S. J Pediatr Hematol Oncol; 2021 Aug 01; 43(6):e819-e825. PubMed ID: 33769390 [Abstract] [Full Text] [Related]
34. CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting. Lim K, Kan WL, Nair PC, Kutyna M, Lopez AF, Hercus T, Ross DM, Lane S, Fong CY, Brown A, Yong A, Yeung D, Hughes T, Hiwase D, Thomas D. PLoS One; 2024 Aug 01; 19(9):e0310641. PubMed ID: 39298477 [Abstract] [Full Text] [Related]
35. Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance. Han W, Zhou F, Wang Z, Hua H, Qin W, Jia Z, Cai X, Chen M, Liu J, Chao H, Lu X. Int J Hematol; 2022 Jan 01; 115(1):21-32. PubMed ID: 34449040 [Abstract] [Full Text] [Related]
38. Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts. Gelsi-Boyer V, Cervera N, Bertucci F, Brecqueville M, Finetti P, Murati A, Arnoulet C, Mozziconacci MJ, Mills KI, Cross NC, Vey N, Birnbaum D. Haematologica; 2013 Apr 01; 98(4):576-83. PubMed ID: 23065512 [Abstract] [Full Text] [Related]